» Articles » PMID: 38392321

Exploring Beyond Common Cell Death Pathways in Oral Cancer: A Systematic Review

Overview
Journal Biology (Basel)
Publisher MDPI
Specialty Biology
Date 2024 Feb 23
PMID 38392321
Authors
Affiliations
Soon will be listed here.
Abstract

Oral squamous cell carcinoma (OSCC) is the most common and lethal type of head and neck cancer in the world. Variable response and acquisition of resistance to traditional therapies show that it is essential to develop novel strategies that can provide better outcomes for the patient. Understanding of cellular and molecular mechanisms of cell death control has increased rapidly in recent years. Activation of cell death pathways, such as the emerging forms of non-apoptotic programmed cell death, including ferroptosis, pyroptosis, necroptosis, NETosis, parthanatos, mitoptosis and paraptosis, may represent clinically relevant novel therapeutic opportunities. This systematic review summarizes the recently described forms of cell death in OSCC, highlighting their potential for informing diagnosis, prognosis and treatment. Original studies that explored any of the selected cell deaths in OSCC were included. Electronic search, study selection, data collection and risk of bias assessment tools were realized. The literature search was carried out in four databases, and the extracted data from 79 articles were categorized and grouped by type of cell death. Ferroptosis, pyroptosis, and necroptosis represented the main forms of cell death in the selected studies, with links to cancer immunity and inflammatory responses, progression and prognosis of OSCC. Harnessing the potential of these pathways may be useful in patient-specific prognosis and individualized therapy. We provide perspectives on how these different cell death types can be integrated to develop decision tools for diagnosis, prognosis, and treatment of OSCC.

Citing Articles

Tissue-resident memory T-cell expressions and their prognostic role in head and neck squamous cell carcinoma: a systematic review and meta-analysis.

Ali A, Bari M, Arshad S, Wahid M, Safdar J, Anwar K BMC Cancer. 2025; 25(1):356.

PMID: 40011911 PMC: 11863602. DOI: 10.1186/s12885-025-13764-2.


A Narrative Review of Prognostic Gene Signatures in Oral Squamous Cell Carcinoma Using LASSO Cox Regression.

Mohd Faizal N, Shai S, Savaliya B, Karen-Ng L, Kumari R, Kumar R Biomedicines. 2025; 13(1).

PMID: 39857718 PMC: 11759772. DOI: 10.3390/biomedicines13010134.


Ferroptosis and oral squamous cell carcinoma: connecting the dots to move forward.

Antonelli A, Battaglia A, Sacco A, Petriaggi L, Giorgio E, Barone S Front Oral Health. 2024; 5:1461022.

PMID: 39296524 PMC: 11408306. DOI: 10.3389/froh.2024.1461022.

References
1.
Cosialls E, El Hage R, Dos Santos L, Gong C, Mehrpour M, Hamai A . Ferroptosis: Cancer Stem Cells Rely on Iron until "to Die for" It. Cells. 2021; 10(11). PMC: 8616391. DOI: 10.3390/cells10112981. View

2.
Zhang T, Wang Y, Inuzuka H, Wei W . Necroptosis pathways in tumorigenesis. Semin Cancer Biol. 2022; 86(Pt 3):32-40. PMC: 11010659. DOI: 10.1016/j.semcancer.2022.07.007. View

3.
Zhao Y, Zhu S . Nrf2/HO-1 Alleviates Disulfiram/Copper-Induced Ferroptosis in Oral Squamous Cell Carcinoma. Biochem Genet. 2023; 62(1):144-155. DOI: 10.1007/s10528-023-10405-w. View

4.
Chen Y, Fan Z, Hu S, Lu C, Xiang Y, Liao S . Ferroptosis: A New Strategy for Cancer Therapy. Front Oncol. 2022; 12:830561. PMC: 8888853. DOI: 10.3389/fonc.2022.830561. View

5.
Jin J, Liu C, Yu S, Cai L, Sitrakiniaina A, Gu R . A novel ferroptosis-related gene signature for prognostic prediction of patients with lung adenocarcinoma. Aging (Albany NY). 2021; 13(12):16144-16164. PMC: 8266333. DOI: 10.18632/aging.203140. View